Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1-kappa
S2X259
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1, kappa
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1
B38
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgM
B38
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, WB
Human
IgG1, kappa
2D2
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, WB
Human
IgG1, kappa
2G7
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, WB
Human
IgG1, kappa
1A1
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, WB
Human
IgG1, kappa
1A8
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, WB
Human
IgG1, kappa
1B2
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, WB
Human
IgG1, kappa
1B6